Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Runke Bioengineering is a prominent biotechnology company specializing in the research, development, and large-scale production of microalgae-derived nutritional ingredients. The company is a leading global supplier of docosahexaenoic acid (DHA) and arachidonic acid (ARA), which are essential fatty acids used extensively in infant formula, dietary supplements, and functional foods. Utilizing proprietary bio-fermentation and microencapsulation technologies, Runke provides high-quality, sustainable alternatives to traditional fish-oil-based sources. Headquartered in Shantou, China, the company operates state-of-the-art GMP-certified manufacturing facilities and maintains a robust R&D center in Guangzhou. Runke is publicly traded on the NEEQ and serves a diverse international clientele, including major global dairy and nutrition brands.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Runke.